To join a alzheimer disease clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are alzheimer disease trials in France?

Active alzheimer disease trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All France Trials → Global alzheimer disease Trials → All Countries → All Trials →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology

Active Trials in France (9)

Memory and Social Interactions

Biobank and Brain Health in Bordeaux.

Nalysis of the Periodontal Microbiota in Elderly Subjects With and Without Alzheimer's Disease: a Case Control Study

Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study

Study of Repetitive Behaviors in Alzheimer's Disease

Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease

Cohort of Patients with Alzheimer's Disease and Their Families.

Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease

Diagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach

Frequently Asked Questions